Member Info for Dazpink

Bought a further 7119 today, in Vlad we trust !

Just cost me £7.03 to top up, wide bid-ask spread

One4one, Get a grip ! please look at yourself before making stupid comments.

The British slang phrase ``get a grip'' is an informal expression that means someone should regain control of their emotions or situation, often implying that they are overreacting or being irrational. It can be used to encourage someone to be more sensible or to stop being overly dramatic

The science is strong Hemo are advancing from preclinical to clinical-stage validation.

Would be nice to have news on the funding required outlined in the prospectus before I jump in again, being cautious but want to invest more sooner rather than later

The Company is of the opinion that the working capital available to the Group will be insufficient for its present

requirements, that is, for at least the next 12 months from the date of this document. Following Admission, the

Directors expect that the Group will have an aggregate funding shortfall of approximately £15.6 million to

enable it to complete the Phase I clinical trials of HG-CT-1 in both adult and pediatric patients over the period

to December 2028.

To address this anticipated funding shortfall, the Group will require additional working capital of approximately

£5.6 million by the end of January 2026 in order to continue its product development activities, with a primary

focus on HG-CT-1, to the end of 2026 and an additional £10 million during the period from 2027 to 2028

Agree GRaff, I am holding until we hear something, very quite at the moment, you just never know

Showing on BBC news, leukaemia patient receives pioneering CAR-T cell therapy treatment, guy having second course, being discharged from hospital no set backs, great news showing its working

Don’t look to the past, thinking about how it used to be a penny share is now irrelevant, keep the faith, it’s what is to come that we focus on. Top up, sit back until positive news comes in on each and every RNS that is released.

Pumpky, I can’t do that, wish I could, fingers burned, already losing £40k on the 30p takeover, more if I take the 25p market price, another bidder could come in who knows.

I am prepared to wait a little longer to get the 30p, hopefully HEMO continues up & down cycle and I can then invest more to re-coup my losses on WOOD

Happy to wait for Vlad to deliver, as soon as I can get my £154k out of WOOD Group I will be filling my boots with HEMO to add to my current pot

More North Sea drilling to be allowed in new Labour plan

New plans to be announced to come to place, why didn’t they act sooner to save WOOD bring owned by another middle east company

Nice time to buy, hoping to top up soon

Vlad will now be waiting for a few more milestones to be ticked off before he agrees for it to be sold for billions.

Makes sense, deals that have recently been completed.

Pharma and Biotech M&As in 2025 Roundup

https://xtalks.com/pharma-and-biotech-mas-in-2025-roundup-4105/

Reality is Hemogenyx are now more engaging and priced at as an attractive investment vehicle, since the share dilution and active progress of its cell therapies and platform technologies for blood diseases.

As a publicly traded clinical-stage biopharmaceutical company it will attract more attention with the data that i5 releases.

The DCNY Summit that Hemo was invited to back in September and also presented at, was an annual high-level forum connecting Washington, DC and New York, bringing together policymakers, investors, corporate leaders, and innovators, this must have resulted in further discussions around funding required which no doubt we will hear about very soon.

Hemo also made numerous other presentations at various investor and scientific conferences, which includes the following:

The H.C. Wainwright Global Life Sciences Conference

The American Society of Hematology Meeting and Exposition

The Immuno-Oncology Summit Europe

The CBD S&T Conference, focusing on biodefense applications

The New York Oncology Investor Conference

Matey, already invested more than I should have done looking back on it now, see how it plays out.

Can’t call it, really not show on this one how the vote will go.

Agree different sector, but both top class companies with excellent employees and brand/relationships

RR had major issues, £2.9bn loss for 2018 period, further issues around the Trent 1000 engines cost them millions as well as no flying income during COVID.

When Turfan Erginbilgic became the new CEO in jan 2023 (ex Oil & Gas man) he made comments that R was a burning platform and required a total transformation, debt reduction plan etc etc.

SMR was in its earliest stage then in design stage.

I invested just after COVID in the belief that a company such as RR with a new CEO and his team had great plans to turn things around, I ignored the negativity from the analysts and waited for it to recover.

Will do the same with WOOD

Not ruled out

RR has 8.4 billion shares,

RR (Rolls-Royce) issued a £2 billion rights issue on October 1, 2020, to help it through the financial impact of the COVID-19 pandemic. The offer allowed shareholders to buy 10 new ordinary shares for every three they already held, at a price of 32 pence per new share.

During it’s recovery after Covid, It was slated by many analysts, it seems all with they own agenda to fill it’s own coffers, now look what it is worth.

Xx the point was most great companies can turn things around and bounce back with good leadership and a change in market sentiment

Xx wasn’t WOOD trading at over £8 a few years ago ?

Oops Kando

Kendo is talking rubbish again.

Worth sharing this, even though it isn’t oil and gas, Interesting to see Keir group doing well now, it struggled significantly in the recent past, particularly between 2018 and 2021, facing a debt crisis that brought the company close to collapse.

Kier Group: already up 41% this year, AGM Trading Update gives confidence for shares at 205p

Following the issue of yesterday’s AGM Trading Update by Kier Group (LON:KIE) analyst Max Hayes, at Cavendish Capital Markets, has stated that it underpins his firm’s confidence in its 277p a share Target Price